Cherokee Nation Technologies LLC, a native tribe, doing business as CNT, Catoosa, Oklahoma, is being awarded a $55,067,430 firm-fixed-price order, HT0011-18-F-0022. This order provides services to assist the Assistant Secretary of Defense [Read more]
AbCellera Biologics Inc. this week announced that it was awarded a contract from the Defense Advanced Research Projects Agency (DARPA) to develop rapid countermeasures against viral outbreaks. Under DARPA’s Pandemic Prevention Platform (P3) [Read more]
Researchers at Texas Biomedical Research Institute in San Antonio have been awarded a $2 million dollar contract by the makers of ZMapp, Mapp Biopharmaceutical, Inc., to further test this promising new therapeutic [Read more]
The Defense Advanced Research Projects Agency (DARPA) launched the Pandemic Prevention Platform (P3) program in 2017, with the eventual goal of halting the spread of any infectious disease outbreak before it can escalate into a pandemic. [Read more]
The National Opinion Research Center at the University of Chicago has been awarded a contract in support of the National Center for Immunizations and Respiratory Diseases (NCIRD) Influenza Division of the Centers [Read more]
General Atomics Electromagnetic Systems (GA-EMS) has been awarded a contract from the Defense Advanced Research Projects Agency (DARPA) to develop a next generation Portable Diagnostic Platform for personnel to quickly self-perform testing [Read more]
Battelle has been awarded a contract by the Intelligence Advanced Research Projects Activity (IARPA) to develop threat assessment software to help prevent the creation of dangerous organisms. IARPA’s Functional Genomic and Computational Assessment [Read more]
The Intelligence Advanced Research Projects Activity (IARPA) this week announced a multi-year research effort to develop new biosecurity tools under the Functional Genomic and Computational Assessment of Threats (Fun GCAT) program. In [Read more]
The Biomedical Advanced Research and Development Authority (BARDA) has awarded funding to Tangen BioSciences for advanced development of the company’s rapid anthrax diagnostic. The $3,199,221 base period award was announced by BARDA [Read more]
Profectus BioSciences, Inc. has received a contract for up to $22.25 million from the National Institute of Allergy and Infectious Diseases (NIAID), a division of the National Institutes of Health, according to [Read more]
© 2018 Global Biodefense